Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
LENTECHS logo — Developing a new generation of soft, suspended contact lens

LENTECHS

Developing a new generation of soft, suspended contact lens

Founded 2020 United States Columbus, United States 9 employees Venture round Total: $11.07M Biotechnology, Health Care +1

General Information

Company Name LENTECHS
Founded Year 2020
Location United States Columbus, United States
Employees 9
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with LENTECHS. To contact LENTECHS, visit lentechs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does LENTECHS compare?

A PDF of LENTECHS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting LENTECHS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About LENTECHS

LENTECHS, LLC is a privately-held, clinical stage ophthalmic medical device company that aims to revolutionize the contact lens industry with its new generation of soft, suspended contact lens. APIOC™, the flagship contact lens platform, features a patented design for suspension of the lens from behind the upper eyelid, based on the anatomy of the eye. Founded in 2017 by optometrist inventors Melissa Bailey, OD, PhD and Joe Barr, OD, MS, FAAO, LENTECHS has successfully developed its core technology licensed from The Ohio State University. The company is set to launch APIOC for Presbyopia and APIOC for Presbyopia with Astigmatism in early-2022, offering presbyopic individuals the possibility of achieving glasses-like vision with the freedom of a soft contact lens. LENTECHS, headquartered in Columbus, Ohio, has garnered significant support from a network of investors committed to pushing the boundaries of innovation in contact lenses. The most recent $6.00M Venture Round investment on 24 October 2023 involved notable backers including Rev1 Ventures, Ohio Innovation Fund, Bluestem Capital, and the JobsOhio Growth Capital Fund. With its groundbreaking technology and strong financial backing, LENTECHS is poised to make a significant impact in the fields of biotechnology and healthcare.

Business keywords: ophthalmic medical device, contact lens technology, presbyopia, astigmatism, eye health, innovation, optometry, startup, clinical stage company, investors, innovative technology, ophthalmology, vision correction, medical innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $6.00M 4
Rev1 Ventures Ohio Innovation Fund JobsOhio
Rev1 Ventures, Ohio Innovation Fund +2
24 Oct 2023
Venture Round $1.47M -
08 Feb 2023
Debt Financing $1.75M -
16 Nov 2021
Debt Financing $1.85M -
13 Apr 2020
Seed Round Undisclosed 2
Rev1 Ventures Baker & Eastlack Ventures
Rev1 Ventures, Baker & Eastlack Ventures
22 Mar 2018

LENTECHS Alternatives & Competitors

View All Alternatives
LENTECHS vs
SynergEyes, Inc.
SynergEyes, Inc. United States

SynergEyes is a leading expert in specialty contact lenses for both Normal and Irregular Corneal Con...

53 employees
Health Care, Manufacturing
LENTECHS vs
Refocus Group
Refocus Group

Pioneering groundbreaking medical solutions for vision disorders, with a focus on presbyopia treatme...

Biotechnology, Health Care
LENTECHS vs
PowerVision, Inc.
PowerVision, Inc. United States

Restoring True Vision for All Distances

Series D
13 employees
Biotechnology, Health Care
View all alternatives

FAQ About LENTECHS

Developing a new generation of soft, suspended contact lens
LENTECHS was founded in 2020.
LENTECHS is headquartered in Columbus, United States.
LENTECHS operates in Biotechnology, Health Care and Medical Devices. Its work centres on ophthalmic medical device, contact lens technology, presbyopia and astigmatism.
LENTECHS has approximately 9 employees.
LENTECHS has completed 5 funding rounds, raising a total of $11.07M. The latest funding stage is Venture round.
Top alternatives and competitors to LENTECHS include SynergEyes, Inc., Refocus Group, PowerVision, Inc., Adaptilens, Atia Vision. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LENTECHS and SynergEyes, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for LENTECHS, https://bouncewatch.com/company/lentechs, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes